Navigation Links
UTSA wins San Antonio Area Foundation grant to further chlamydia research
Date:6/23/2009

San Antonio Ashlesh Murthy, the newest research assistant professor in the South Texas Center for Emerging Infectious Diseases (STCEID) at The University of Texas at San Antonio (UTSA), has received a $32,000 grant from the Semp Russ Foundation of the San Antonio Area Foundation to study the role of CD8-positive T-cells in chlamydia infections. Chlamydia, caused by the bacterium Chlamydia trachomatis, is the nation's most common bacterial sexually transmitted disease.

Nearly 2.8 million new chlamydia cases are reported each year in the United States, according to the Centers for Disease Control and Prevention; the disease is most prevalent among teen girls. The infection rate in Texas is slightly higher than the national average. Nearly 17% of Texas females in the 15-19 age group test positive for the infection.

However, experts believe even more chlamydia cases exist than are reported, because the disease generally progresses without exhibiting noticeable symptoms. Left untreated, chlamydia infections can do severe damage in women, causing ectopic pregnancies, pelvic inflammatory disease and even infertility. In men, complications can occur but are generally less severe.

Murthy, a practicing physician from India, entered the Ph.D. program in cellular and molecular biology (CMB) at UTSA in 2002. Working alongside Bernard Arulanandam, professor of microbiology and immunology in UTSA's Department of Biology, Murthy has conducted significant chlamydia research, resulting in findings that have been presented both nationally and internationally by UTSA's chlamydia team.

In 2006, Murthy earned his Ph.D., the first CMB Ph.D. degree awarded by the university. Thereafter, he completed two years of post-doctoral research in UTSA's infectious disease center. Recently, he joined UTSA's Department of Biology as a research assistant professor. The San Antonio Area Foundation award is Murthy's first funding as principal investigator.

"We know that CD8-positive T-cells respond to chlamydia infection, but it is not clear how they affect the infection process and disease development," said Murthy, the study's principal investigator. "The grant from the San Antonio Area Foundation will help us explore the role of these cells and obtain better insights."


'/>"/>

Contact: Christi Fish
christi.fish@utsa.edu
210-458-7584
University of Texas at San Antonio
Source:Eurekalert

Related biology news :

1. Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25
2. CTRC-AACR San Antonio Breast Cancer Symposium
3. 31st Annual San Antonio Breast Cancer Symposium
4. The BBVA Foundation presents its Frontiers of Knowledge Awards
5. Five outstanding young gastroenterologists receive AGA Foundation 2009 Research Scholars Award
6. Society of Interventional Radiology Foundation awards $191,000 in grants
7. The evolutionary foundation of genomic imprinting in lower vertebrates
8. UC Davis bioengineer receives Hartwell Foundation grant to address skull fusion disorder of infants
9. G. Unger Vetlesen Foundation funds purchase of state-of-the-art equipment for UMs Rosenstiel School
10. $10 million Simons Foundation gift supports new initiative with Institute for Advanced Study
11. Innerscope Research(R) Receives Three Great Minds Innovation Awards from the Advertising Research Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2017)... MINNETONKA, Minn. , Feb. 7, 2017   ... that supports the entire spectrum of clinical research, is ... iMedNet , its innovative, highly flexible and ... iMedNet customers. iMedNet is a ... only provides Electronic Data Capture (EDC), but also delivers ...
(Date:2/6/2017)... According to Acuity Market Intelligence, ongoing ... to continue to embrace biometric and digital identification ... Border Control (ABC) eGates and 1436 Automated Passport ... 163 ports of entry across the globe. Deployments ... combined CAGR of 37%. APC Kiosks reached 75% ...
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... February 27, 2017 Four US ... evaluation today, and they are: Anthera Pharmaceuticals Inc. (NASDAQ: ... California Inc. (NASDAQ: PACB), and Conatus Pharmaceuticals Inc. (NASDAQ: ... ETF Trends, market observers are growing more bullish on ... enact reforms to free cash held overseas for tax ...
(Date:2/26/2017)... ... ... Rob Lowe is a well recognized television personality, so it seems natural he would ... important to the American public and important to society at large. An upcoming episode ... the world for a few years. , The climate and how we relate to ...
(Date:2/24/2017)... KNOXVILLE, Tenn. , Feb. 24, 2017 /PRNewswire/ ... ) ("Provectus" or the "Company"), a clinical-stage oncology ... information regarding the deadline to participate in its ... million units, consisting of shares of common stock ... stockholders and holders of listed warrants. ...
(Date:2/24/2017)... Staten Island, NY (PRWEB) , ... February 24, 2017 , ... ... exponential rate. Founded in late 2014, FireflySci had the goal of bringing their ... 2017, that goal continues to shape the path that FireflySci is going on as ...
Breaking Biology Technology: